HEALTHGUARDIAN US
US health panel recommends easing restrictions on controversial peptides
A US federal health advisory panel recommended easing restrictions on peptides like BPC-157, TB-500, and KPV, despite warnings from government scientists about their safety and effectiveness. The panel includes members linked to the peptides industry, and the decision may influence RFK Jr.'s stance.
Mentioned
Related Signal
Adjacent reporting
- US health panel recommends easing restrictions on controversial peptides
- FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr.
- FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.